144 related articles for article (PubMed ID: 12749728)
21. Proteomics: methodologies and applications in oncology.
Wouters BG
Semin Radiat Oncol; 2008 Apr; 18(2):115-25. PubMed ID: 18314066
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.
Tanase CP; Codrici E; Popescu ID; Mihai S; Enciu AM; Necula LG; Preda A; Ismail G; Albulescu R
Oncotarget; 2017 Mar; 8(11):18497-18512. PubMed ID: 28061466
[TBL] [Abstract][Full Text] [Related]
23. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
24. Proteomics: recent applications and new technologies.
Elrick MM; Walgren JL; Mitchell MD; Thompson DC
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
[TBL] [Abstract][Full Text] [Related]
25. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.
de Noo ME; Tollenaar RA; Deelder AM; Bouwman LH
World J Gastroenterol; 2006 Nov; 12(41):6594-601. PubMed ID: 17075970
[TBL] [Abstract][Full Text] [Related]
26. Cancer heterogeneity determined by functional proteomics.
Szász AM; Győrffy B; Marko-Varga G
Semin Cell Dev Biol; 2017 Apr; 64():132-142. PubMed ID: 27569188
[TBL] [Abstract][Full Text] [Related]
27. The application of proteomic techniques to fungal protein identification and quantification.
Rohrbough JG; Galgiani JN; Wysocki VH
Ann N Y Acad Sci; 2007 Sep; 1111():133-46. PubMed ID: 17344531
[TBL] [Abstract][Full Text] [Related]
28. Experimental and computational approaches to quantitative proteomics: status quo and outlook.
Panchaud A; Affolter M; Moreillon P; Kussmann M
J Proteomics; 2008 Apr; 71(1):19-33. PubMed ID: 18541471
[TBL] [Abstract][Full Text] [Related]
29. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
Smith L; Lind MJ; Welham KJ; Cawkwell L;
Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413
[TBL] [Abstract][Full Text] [Related]
30. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
31. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
Jimenez CR; Verheul HM
Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
[TBL] [Abstract][Full Text] [Related]
32. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
33. Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure.
Faber MJ; Agnetti G; Bezstarosti K; Lankhuizen IM; Dalinghaus M; Guarnieri C; Caldarera CM; Helbing WA; Lamers JM
Cell Biochem Biophys; 2006; 44(1):11-29. PubMed ID: 16456231
[TBL] [Abstract][Full Text] [Related]
34. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.
Wulfkuhle JD; Paweletz CP; Steeg PS; Petricoin EF; Liotta L
Adv Exp Med Biol; 2003; 532():59-68. PubMed ID: 12908550
[TBL] [Abstract][Full Text] [Related]
35. Proteomic technologies for biomarker studies in psychiatry: advances and needs.
Martins-de-Souza D; Guest PC; Vanattou-Saifoudine N; Harris LW; Bahn S
Int Rev Neurobiol; 2011; 101():65-94. PubMed ID: 22050849
[TBL] [Abstract][Full Text] [Related]
36. Oncoproteomics: current trends and future perspectives.
Cho WC; Cheng CH
Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
[TBL] [Abstract][Full Text] [Related]
37. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
[TBL] [Abstract][Full Text] [Related]
38. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
39. Proteomics to diagnose human tumors and provide prognostic information.
Ornstein DK; Petricoin EF
Oncology (Williston Park); 2004 Apr; 18(4):521-9; discussion 529-32. PubMed ID: 15134357
[TBL] [Abstract][Full Text] [Related]
40. Genomics and proteomics: emerging technologies in clinical cancer research.
Chung CH; Levy S; Chaurand P; Carbone DP
Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
